CLINICAL_TRIALS
trial_result
· 2021-02-11
Clinical Trial Update: the Effect of Cerebrolysin on Physical and Mental Functions of Down Syndrome [Phase 2]
Summary
Phase 2 clinical trial evaluating the effects of Cerebrolysin on physical and mental functions in individuals with Down syndrome has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Mansoura University Children Hospital | Conditions: Down Syndrome | Phase 2 | Status: COMPLETED